Cancer of the skin, skeleton, and soft tissues presents with a wide variety of manifestations. Depending on the tumor type, its aggressiveness, and the presence or absence of other pathologies, symptoms can vary significantly. Therefore, it is important to pay attention to the following signs.

Skin Cancer

Skin cancer is relatively easy to detect because it manifests with superficial, cutaneous signs. However, even a qualified and experienced specialist may not always be able to recognize the malignant nature of such lesions: without histological examination, it is impossible to determine the nature of the neoplasm and whether treatment for skin cancer or a “routine” dermatological condition is required.

You should consult a doctor without delay if even one of the following signs of possible melanoma, basal cell carcinoma, etc., is observed:

appearance of a mole, scaling, oozing, induration, sore, or ulcer on any part of the body that is increasing in size;
a previously existing mole has grown in size, its borders have changed, it has become raised or, conversely, depressed into the skin;
itching, burning, pain, or other discomfort in the area of a mole, induration, etc.

It is important to remember that skin cancers are more likely to develop in people who excessively pursue tanning, work outdoors without skin protection from UV rays, and in individuals with a family history of melanoma, basal cell carcinoma, etc.

Skeletal Cancer

Skeletal cancer can be a primary disease, with the tumor developing in the bone tissue. It can also be a secondary process, with metastases developing from a malignant neoplasm present in other organs. For example, bone and soft tissue sarcomas — such as fibrosarcoma — are often encountered; they predominantly affect connective tissues: cartilage, tendons, and muscles.

Signs that may indicate a possible malignant process in any part of the skeleton include:

unexplained swelling in any area of the body;
pain, tension, or pronounced discomfort in a specific skeletal region;
bone fractures triggered by minor trauma that would not normally cause bone damage;
significant and sudden weight loss that cannot be explained by reduced caloric intake or increased physical activity.

These are general symptoms of bone cancer. Depending on the location of the malignant process, the presence or absence of metastases, and involvement of internal organs and tissues, additional symptoms such as headache, marked reduction in mobility, and severe fatigue may also occur. Treatment for skeletal cancer is prescribed only after a comprehensive and complete examination and detailed assessment of all disease factors.

Soft Tissue Cancer

Soft tissue cancer is one of the rarest types of malignant processes — and this is precisely what makes it dangerous. Not every doctor a patient consults for nonspecific symptoms will suspect an oncological condition and refer the patient to a specialist.

Therefore, it is important to know how soft tissue cancer may manifest so that you can consult an oncologist in a timely manner. Desmoid fibromas, intra and extraabdominal, and multifocal tumors may present with the following manifestations:

a lump or induration anywhere on the body — initially painless, later causing pain or discomfort as the tumor begins to press on adjacent structures;
sensory disturbances in the area with the soft tissue neoplasm (numbness, paresthesia, sensation of cold or heat);
dysfunction of the organ involved in the tumor process (e.g., problems with bowel or bladder emptying, reduced joint range of motion, etc.).

Treatment for soft tissue cancer requires the involvement of multiple medical specialists — from oncologists and radiologists to surgeons and morphologists.

Diagnosis

Treatment for skin, skeletal, and soft tissue cancers begins with diagnosis. This is necessary to assess all characteristics of the tumor: its causes, type, extent of spread, presence or absence of metastases, and involvement of internal organs, soft tissues, bones, etc., in the pathological process.

Treatment for skin cancer usually starts with a consultation with a dermatologist or oncologist. Based on the physical examination and medical history, the patient is referred for instrumental and laboratory diagnostics. This includes a biopsy of cells from the suspicious skin area and, in some cases, the underlying soft tissues. This study is usually sufficient to determine whether the neoplasm is malignant (e.g., melanoma, basal cell carcinoma) or benign. Contrast radiography, CT, PET/CT, or MRI may also be prescribed at the physician’s discretion.

Treating soft tissue cancer requires determining the exact tumor location, differentiating it from other pathologies with similar clinical presentations, and assessing the extent of spread. Desmoid fibroma and extra and intraabdominal tumors may be examined via endoscopic methods or diagnostic surgery, depending on where in the soft tissues the malignant process has developed.

Bone cancer is diagnosed based on conventional and contrast radiography, as well as CT or MRI to determine whether the process has spread into the soft tissues.

In all cases — whether melanoma, desmoid fibroma, bone and soft tissue sarcoma, or another type of disease is detected — laboratory tests are performed (biochemical and complete blood counts, tumor marker tests, etc.). These are important for assessing internal organ function and developing a treatment program.

Treatment for Skeletal, Skin, and Soft Tissue Cancers

Treatment for skeletal, skin, and soft tissue cancers is tailored to the specifics of the clinical case. Factors considered include the location and extent of the tumor in the skeleton, soft tissues, or skin; the disease stage; the patient’s age; the presence of other conditions; and the prognosis associated with that particular cancer type.

For soft tissue and skin cancers, surgery is the main treatment approach. During the operation, the desmoid fibroma, basal cell carcinoma, or other neoplasm is removed.

Surgical treatment for skeletal cancer can be challenging when the tumor is located in the spine, facial skeleton, or cranial vault.

Therefore, for bone and soft tissue sarcomas, chondrosarcoma, etc., therapy is selected strictly on an individual basis, after carefully weighing all risks and benefits.

Treatment for cancer of the skin, skeleton, connective, or muscle tissues, etc., usually involves a combination of several methods. Chemotherapy is often the firstline approach: it can slow tumor growth and reduce its size before surgery, and after surgery, it can destroy any cancer cells that might have been missed. Radiological treatment (radiation) follows a similar principle but is more commonly used for bone cancer.